All the major pharma companies will be knocking it off as well as all the giant generic drug makers who have this patent expiration process down to a science. Far bigger better funded players also looking to do the same thing. You have no patent, no exclusivity, you are just one of the first one's to announce a deal so far ahead of 2015 expiration of that patent. That's why Spectrum threw a couple of bucks VPRO's way....jmho!
Market Data 
Markets 
AI
